Vicor Technologies, Inc; Predicting risk of Sudden Cardiac Death

I read an article in Health Journal, June 24th, about Vicor's PD2i Cardiac Analyzer. It uses an algorithm that can assess a patient's risk to die from Sudden Cardiac Death (SCD) by analyzing heart beats. The PD2i has the ability of predicting SCD, with greater than 95% sensitivity and 81% specificity within a six month period. The test can be administered in a cardiologist's office in 20 minutes. This device could save a number of lives.
The PD2i Cardiac Analyzer has garnered the attention of the US Army who want to use Vicor's proprietory cardiac risk assessment for Trauma and Emergency Response. Vicor, in collaboration with the U.S. Army, will evaluate the severity of injury, and probability of survival, for critically injured combat casualties and critically ill civilian patients. As of now the stock is low volume and current market capitalization is about $30 million. It won't take long before the real story of Vicor Technologies (VCRT) and the revenue potential of this stock is realized.